跳至主要内容
临床试验/JPRN-UMIN000005394
JPRN-UMIN000005394已完成4 期

Effect of Active Vitamin D Treatment on Sarcopenia Incidence Among Adults with Prediabetes - Randomized Controlled Trial- - DPVD ancillary trial

niversity of Occupational and Environmental Health Kokura Medical Association, Health Testing Center Fujisawa City Hospital Shin Komonji Hospital0 个研究点目标入组 1,256 人开始时间: 2011年4月7日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
1,256

研究概览

简要总结

During a median follow-up of 2.9 years, 79 (12.5%) of 630 participants in the eldecalcitol group and 89 (14.2%) of 626 in the placebo group developed type 2 diabetes (HR 0.87, 95%CI 0.67 to 1.17, P=0.39). After adjustment for confounding factors by multivariable fractional polynomial Cox regression analysis, eldecalcitol significantly lowered the development of diabetes (HR 0.69, 0.51 to 0.95, P=0.020).

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Individuals who have participated in other clinical trials. 2. Individuals who have been treated with active vitamin D, vitamin D supplement, and/or calcium preparation within the preceding 3-month period. 3. Individuals who have already been diagnosed with type 1, type 2 diabetes, and/or sarcopenia. 4. Individuals in whom drug treatment for prediabetes has been initiated. 5. Individuals who are pregnant or have severe diseases, such as renal insufficiency (serum creatinine of 1.5 mg/dl or higher), hepatic insufficiency, psychosis, collagen diseases, heart diseases, and cerebrovascular diseases. 6. A sub investigator may preclude participant involvement in the study based on screening and assessment of the participants condition.

研究者

发起方
niversity of Occupational and Environmental Health Kokura Medical Association, Health Testing Center Fujisawa City Hospital Shin Komonji Hospital

相似试验